The clinical research program at Georgia Cancer Specialists focuses on making targeted cancer therapy accessible to as many patients as possible. With six research sites in Metro Atlanta, Macon, and Athens, patients across the state are able to take part in cutting edge clinical trials targeting all types of cancer, including lung cancer, breast cancer, lymphoma, colon cancer, and prostate cancer.
Because of our strong commitment to research, GCS is affiliated with the Northside Hospital Cancer Institute, one of one of only 21 cancer programs in the United States to be selected by the National Cancer Institute to participate in the NCI Community Cancer Centers Program (NCCCP). As a NCCCP, GCS and the Northside Hospital Cancer Institute will seek to increase patient participation in clinical trials and promote genomically-informed research (also known as personalized medicine).
Through an affiliation with the University of Alabama-Birmingham Comprehensive Cancer Center (UABCCC), GCS is able to offer leading-edge cancer care to GCS patients. GCS is the only private cancer practice in Georgia to offer Phase I clinical trials.
Dr. Mansoor Saleh, MD Mansoor Saleh, MD is the director of clinical research at GCS and is also a professor of medicine at UABCCC. He has overseen the research program at GCS for more than a decade and monitors trials from our
Northside location. Currently, fourteen other sub-investigators oversee the treatment of all GCS patients on clinical trials. The research team is comprised of physicians and specialized clinical staff trained in research design, data collection, and analysis.